LENTIGLOBIN GENE THERAPY FOR TRANSFUSION DEPENDENT B-THALASSEMIA: UPDATE FROM THE NORTHSTAR HGB-204 PHASE 1/2 CLINICAL STUDY

Rasko, J; Thompson, A; Kwiatkowski, J; Hongeng, S; Schiller, GJ; Anurathapan, U; Cavazzana-Calvo, M; Ho, P; von Kalle, C; Kletzel, M; Leboulch, P; Vichinsky, E; Petrusich, A; Asmal, M; Walters, M

CYTOTHERAPY, 2017; 19 (5): S19